Validation of Cleaning Procedures for Highly Potent Drugs. I. Losoxantrone
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 1 (1) , 69-75
- https://doi.org/10.3109/10837459609031420
Abstract
The validation of a procedure designed to clean glass and stainless steel surfaces after exposure to the experimental anticancer drug losoxantrone is described. The cleaning procedure, using water and hypochlorite bleach, was validated using a wipe test and a high-performance liquid chromatography (HPLC) method developed to quantitate low levels of losoxantrone. The HPLC method is shown to be linear and reproducible (relative standard deviation (RSD): 7.1% or less), with a detection limit of 2 ng/ml. Recoveries of 71.0%, 50.1%, and 57.6% were reproducibly obtained from the wipe pads, glass plates, and stainless steel plates, respectively, at levels of 70–140 ng per 100 cm2. The cleaning procedure is shown to clean glass and stainless steel plates to less than 20 ng and 17 ng losoxantrone per 100 cm2, respectively. These results demonstrate the need to fully characterize the recovery of drugs from surfaces and swabs in order to properly validate cleaning procedures.Keywords
This publication has 8 references indexed in Scilit:
- An evaluation of the use of capillary electrophoresis to monitor trace drug residues following the manufacture of pharmaceuticalsChromatographia, 1995
- Topoisomerase II Inhibition and Cytotoxicity of the Anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute Preclinical Antitumor Drug Discovery ScreenJNCI Journal of the National Cancer Institute, 1994
- Occupational exposure to antineoplastic agents at several departments in a hospitalInternationales Archiv für Arbeitsmedizin, 1992
- Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.Journal of Clinical Oncology, 1991
- Determination of Cefsulodin, Cefmenoxime, and Cefadroxil as Residues on SurfacesPharmaceutical Research, 1991
- Anticancer anthrapyrazoles. Improved syntheses of clinical agents CI-937, CI-941, and piroxantrone hydrochlorideJournal of Heterocyclic Chemistry, 1989
- Cleaning ValidationDrug Development and Industrial Pharmacy, 1989